Nature's Sunshine Products, Inc.

As of October 17, 2025, Nature's Sunshine Products, Inc. is considered overvalued with a P/E ratio of 26 compared to the peer average of 21.11, and its 6.30% return over the past year is significantly lower than the S&P 500's 14.08% return, leading to a valuation grade downgrade from attractive to fair.

As of October 17, 2025, Nature's Sunshine Products, Inc. is considered overvalued with a P/E ratio of 26 compared to the peer average of 21.11, and despite a notable three-year return of 64.31%, it still lags behind the S&P 500's 81.19%.

As of October 17, 2025, Nature's Sunshine Products, Inc. is considered fairly valued but appears overvalued with a P/E ratio of 26 compared to the peer average of 21.11, a lower YTD return of -3.27% versus the S&P 500's 13.30%, and a ROE of 6.38% that suggests insufficient shareholder returns relative to equity costs.

As of September 3, 2025, Nature's Sunshine Products, Inc. shows a bullish technical trend supported by positive MACD and moving averages, despite a bearish monthly RSI, with a year-to-date return of 14.26%, outperforming the S&P 500.

As of August 6, 2025, Nature's Sunshine Products, Inc. is considered overvalued with a P/E ratio of 26, an EV to EBITDA ratio of 5.08, and a Price to Book Value of 1.65, despite a 1-year return of 23.71% that outperformed the S&P 500.

As of October 1, 2023, there is insufficient technical data for Nature's Sunshine Products, Inc. to determine a bullish or bearish outlook.

As of October 1, 2023, Nature's Sunshine Products, Inc. is considered attractive and undervalued with a P/E ratio of 15.2, compared to peers like Herbalife at 18.4 and USANA at 16.1, and has shown positive returns relative to the Sensex.

As of March 2022, the management team of Nature's Sunshine Products, Inc. includes J. Christopher Teets (Independent Chairman), Terrence Moorehead (CEO), and several independent directors: Robert Mercer, Richard Moss, Mary Springer, Robert Straus, and Heidi Wissmiller. The team features a blend of executive leadership and independent oversight.

Nature's Sunshine Products, Inc. is a micro-cap company that manufactures and sells natural health and wellness products, with recent net sales of $113 million and a net profit of $5 million. Key financial metrics include a P/E ratio of 26.00 and a market cap of $274.73 million.

As of Jun 18, Nature's Sunshine Products, Inc. has a market capitalization of 274.73 million, with net sales of 456.61 million and a net profit of 10.29 million over the last four quarters. Shareholder's funds are 155.31 million, and total assets amount to 240.85 million.